Method of treating dyspnea associated with acute heart failure. Relaxin H2. Use.

摘要

Methods to reduce the intervention including acute decompensation in patients affected with acute decompensated heart failure. Methods of treatment of acute decompensation cardaca through administration of a pharmaceutically effective amount of Relaxin.Claim 1: Relaxin H2 with Pharmaceutical activity which is for use in a method for treating dyspnea in a Human subject.Claim 55: Use of Relaxin H2 with Pharmaceutical activity and is characterized in that an antihypertensive drugs in the manufacture of a Medicament for treating dyspnea () in a Human subject; (b) Acute decompensated congestive cardaca in a Human subject.Where the subject has a sangunea decompensated heart failure and systolic pressure of at least 125 mm Hg; or (c) Acute decompensated heart failure in a Human subject, where the subject has acute decompensated heart failure and an ejection fraction of ventrculo I Zquierdo of at least 20%.